Biofrontera (BFRI) Change in Receivables (2020 - 2025)

Biofrontera's Change in Receivables history runs 6 years deep, the most recent figure standing at $4.3 million for Q4 2025.

• On a quarterly basis, Change in Receivables rose 768.29% year-over-year to $4.3 million in Q4 2025; TTM through Dec 2025 was $1.9 million, a 505.4% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 505.4% from the prior year.
• Change in Receivables rose to $4.3 million in Q4 2025 per BFRI's latest filing, from -$947000.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $4.3 million in Q4 2025 and bottomed at -$3.1 million in Q2 2022.
• The 5-year median for Change in Receivables is $149500.0 (2021), against an average of $222000.0.
• Across the five-year window, Change in Receivables plunged 30900.0% in 2022 and surged 768.29% in 2025, its largest moves.
• Year by year, Change in Receivables stood at $1.8 million in 2021, then grew by 19.7% to $2.2 million in 2022, then slumped by 38.93% to $1.3 million in 2023, then slumped by 63.06% to $492000.0 in 2024, then surged by 768.29% to $4.3 million in 2025.
• Per Business Quant, the three latest BFRI Change in Receivables figures stand at $4.3 million (Q4 2025), -$947000.0 (Q3 2025), and -$88000.0 (Q2 2025).